6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Organon and Co
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Continue to meet all demographic and procedural
this extension trial.
Have demonstrated an acceptable degree of compliance
and completed the A7501013 trial, and would benefit
from continued treatment according to the investigator.
You may not be if
Have an uncontrolled, unstable clinically significant
medical condition.
Have been judged to be medically noncompliant in the
management of their disease.
Clareo Health | 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)
